因本次交易尚处于筹划阶段，存在不确定性，为保证公平信息披露，维护投资者利益，避免造成公司股 价异常波动，根据上海证券交易所相关规定，经公司向上海证券交易所申请，公司A股股票(简称：中 国神华，股票代码：601088)自2025年8月4日开市起开始停牌，预计停牌时间不超过10个交易日。 根据国家能源集团公司出具的《关于筹划重大事项的通知》，拟由公司通过发行A股股份及支付现金方 式购买国源电力、化工公司、新疆能源、乌海能源、包头矿业、神延煤炭、晋神能源、平庄煤业、内蒙 建投、煤炭运销公司、港口公司、航运公司、电子商务公司的股权，具体方案尚待进一步商讨确定，并 视具体情况募集配套资金。 截至本公告日期，本次交易仍处于筹划阶段，交易各方尚未签署正式的交易协议。 中国神华（601088）(01088)公布，2025年8月1日，公司收到控股股东国家能源投资集团有限责任公司 (国家能源集团公司)的《关于筹划重大事项的通知》，初步考虑拟由该公司发行A股股份及支付现金购 买国家能源集团公司持有的煤炭、坑口煤电以及煤制油煤制气煤化工等相关资产并募集配套资金。 根据《上市公司重大资产重组管理办法》等相关法律法规的规定，本次交易构成 ...

Core Viewpoint - China Shenhua announced plans to acquire coal, coal power, and coal chemical assets from its controlling shareholder, China Energy Group, through a share issuance and cash payment, while also raising supporting funds [2][5]. Group 1: Transaction Details - The transaction involves acquiring assets from China Energy Group, including stakes in various subsidiaries such as Guoyuan Power Co., China Shenhua Coal-to-Oil Chemical Co., and others [5]. - The specific assets for the restructuring are still under evaluation, and the final asset scope will be disclosed in future announcements [7]. - The transaction is classified as a related party transaction and is not expected to constitute a major asset restructuring, with no change in the company's actual controller [7]. Group 2: Stock Suspension - China Shenhua's A-share stock will be suspended from trading starting August 4, with the suspension expected to last no more than 10 trading days [2][6]. Group 3: Performance Forecast - For the first half of 2025, China Shenhua anticipates a decline in net profit, projecting a range of 23.6 billion to 25.6 billion yuan, representing a decrease of 39 million to 59 million yuan, or a decline of 13.2% to 20% compared to the previous year [8].

Core Viewpoint - China Shenhua (601088) announced plans to issue shares and pay cash to acquire assets from its controlling shareholder, China Energy Investment Corporation, leading to a temporary suspension of its stock trading starting August 4, with an expected duration of no more than 10 trading days [1] Group 1 - The company received a notification from its controlling shareholder regarding the planning of significant matters, which includes the potential acquisition of coal, coal power, and coal chemical assets [1] - The transaction is classified as a related party transaction and is not expected to constitute a major asset restructuring, nor will it lead to a change in the company's actual controller [1] - The company indicated that the transaction is still uncertain, and specific details will be disclosed in future announcements regarding the restructuring plan or report [1] Group 2 - As of the close on August 1, China Shenhua's stock price was 37.56 yuan per share, with a total market capitalization of 746.3 billion yuan [1]

中国神华公告，因筹划发行股份及支付现金购买资产并募集配套资金暨关联交易事项，公司A股股票自 2025年8月4日开市起停牌，预计停牌时间不超过10个交易日。本次交易涉及国家能源集团持有的煤炭、 坑口煤电以及煤制油煤制气煤化工等相关资产，交易对方初步确定为国家能源集团及其西部能源投资有 限公司。本次交易尚处于筹划阶段，存在不确定性，最终能否实施尚存在不确定性。 ...

格隆汇8月1日丨慈星股份（维权）(300307.SZ)公布，公司原拟通过发行股份及支付现金的方式购买阳 顺义科技股份有限公司（简称"顺义科技"）的75%股份，并拟向不超过35名特定投资者发行股票募集配 套资金。自筹划本次交易以来，公司严格按照相关法律法规及规范性文件要求，积极组织交易各相关方 推进本次重组工作。但经进行多轮协商和谈判后，公司与本次交易的部分交易对方就部分商业条款未达 成一致意见，为维护公司全体股东长期利益，公司经审慎性考虑，决定终止本次重组事项。 ...

公司拟发行股份购买中国化工装备有限公司持有的益阳橡胶塑料机械集团有限公司100%股权、北京蓝 星节能投资管理有限公司持有的蓝星（北京）化工机械有限公司100%股权，并向不超过35名符合条件 的特定投资者发行股份募集配套资金。2025年7月25日，公司召开第八届董事会第十九次会议，审议通 过了《关于公司发行股份购买资产并募集配套资金暨关联交易方案的议案》等与本次交易相关的议案。 本次交易构成关联交易，预计构成重大资产重组、不构成重组上市。本次交易涉及的审计、评估工作尚 未完成。本次交易尚需履行必要的内部决策程序，并需经有权监管机构批准后方可正式实施，本次交易 的相关审批程序能否通过及通过时间尚存在一定不确定性。 格隆汇7月31日丨中化装备(600579.SH)公布，公司股票于2025年7月29日、2025年7月30日连续2个交易 日内收盘价格涨幅偏离值累计达到20%以上，触及股票交易异常波动后，2025年7月31日继续涨停， 2025年7月31日换手率为18.15%。公司股价连续3个交易日累计涨幅达33.13%，高于同期行业涨幅，敬 请广大投资者注意二级市场交易风险，理性决策，审慎投资。 ...

Group 1 - Company Shenzhou New Materials has experienced multiple instances of abnormal stock trading fluctuations and will be suspended from trading starting July 31, 2025, for up to three trading days [1] - The stock price of Shenzhou New Materials has increased over 1288% this year, making it the first tenfold stock of 2025 [1] - Company Yangtze Power plans to invest approximately 26.6 billion yuan in the construction of the Gezhouba shipping capacity expansion project, with funding sourced from its own funds [2] - Yonghui Supermarket intends to raise no more than 3.992 billion yuan through a private placement of A-shares for store upgrades and logistics improvements [3] Group 2 - Chipsea Technology is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its international strategy and competitiveness [4] - Zhongwang Software is facing a copyright infringement lawsuit from Autodesk in a California federal court, with the amount in dispute yet to be determined [5] - Jinchengzi is planning to acquire 55% of the equity of Changchun Samit Optoelectronics Technology Co., Ltd., and will suspend trading starting July 31, 2025, for up to ten trading days [6] - Nanxin Pharmaceutical is in the process of planning the acquisition of a domestic pharmaceutical technology asset group, with significant uncertainty regarding whether it constitutes a major asset restructuring [7] Group 3 - Huaheng Biological is preparing to issue H-shares and list on the Hong Kong Stock Exchange to advance its global strategy [9] - Sanchao New Materials is planning a change in company control and will suspend trading starting July 31, 2025, for up to two trading days [10] - Digital Certification's controlling shareholder will change to Beijing Data Group following a transfer of state-owned shares [11] - Hongxiang Co., Ltd.'s actual controller has been placed under residential surveillance, but this will not affect the company's normal operations [12]

公告显示，南新制药股票交易连续三个交易日内（7月28日—30日）收盘价格涨幅偏离值累计达到 30%，根据《上海证券交易所交易规则》《上海证券交易所科创板股票异常交易实时监控细则》的有关 规定，属于股票交易异常波动的情形。7月30日，南新制药收涨20%，收盘价为14.28元/股。 北京商报讯（记者 丁宁）7月30日晚间，南新制药（688189）发布公告称，公司近期正在筹划购买某一 国内药品技术等资产组事项，尚无法确定是否构成重大资产重组。该事项正处于筹划阶段，尚未签署任 何有关收购的意向协议，是否能够顺利实施存在重大不确定性。公司将根据该事项的进展情况及时履行 信息披露义务，具体内容以公司后续公告为准。 ...

人民财讯7月30日电，南新制药(688189)7月30日晚间发布股票交易异常波动公告称，近期正在筹划购买 某一国内药品技术等资产组事项，尚无法确定是否构成重大资产重组。该事项正处于筹划阶段，尚未签 署任何有关收购的意向协议，是否能够顺利实施存在重大不确定性。敬请广大投资者理性投资，注意风 险。 ...

南新制药发布股票交易异常波动公告，公司股票交易连续三个交易日内(2025年7月28日、7月29日和7月 30日)收盘价格涨幅偏离值累计达到30%，根据相关规定，属于股票交易异常波动的情形。公司近期正 在筹划购买某一国内药品技术等资产组事项，尚无法确定是否构成重大资产重组。该事项正处于筹划阶 段，尚未签署任何有关收购的意向协议，是否能够顺利实施存在重大不确定性。公司将根据该事项的进 展情况及时履行信息披露义务。 ...